# FDA 483 - MPS Anzon LLC - August 13, 2021

Source: https://www.keypedia.com/records/483/mps-anzon-llc/19e29b2f-9390-402c-934d-25ddd9f25733

> FDA 483 for MPS Anzon LLC on August 13, 2021. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: MPS Anzon LLC
- Inspection Date: 2021-08-13
- Product Type: other
- Office Name: Division of Pharmaceutical Quality Operations IV
- Summary: An FDA inspection of MPS Anzon LLC in Arcadia, CA, from August 10-13, 2021, revealed deficiencies in the firm's quality system. The primary observation noted inadequate documentation of corrective and preventive action activities. Specifically, the firm failed to conduct a retrospective review after discovering past-due calibration dates for critical in-process and final inspection tools, including some found to be out of tolerance.

## Related Officers

- [Marlo-Ian M. Alintanahin](https://www.keypedia.com/people/marlo-ian-m-alintanahin/a37da927-b369-4753-b275-41743556f25e)

Company: https://www.keypedia.com/companies/mps-anzon-llc/d2c4d676-79f0-45f0-8089-bed1697c816d

Office: https://www.keypedia.com/offices/division-of-pharmaceutical-quality-operations-iv/a2d2ff91-dc0f-433e-b91f-ca90ff8998b6